Pisacane A M, Picciotto F, Risio M
Unit of Pathology, Institute for Cancer Research and Treatment, 10060 Candiolo, Torino, Italy.
Cell Oncol. 2007;29(1):59-66. doi: 10.1155/2007/486579.
Vasculogenic mimicry, as previously described in aggressive melanoma, is characterized by the de novo generation of intratumoral patterned vascular channels, composed of PAS-positive basement membrane in the absence of endothelial cells, providing additional microcirculation, in support to the classic tumoral angiogenesis.
We investigated the immunohistochemical expression of two endothelial markers, CD31 and CD34, in tumoral cells of 60 melanomas (45 primary cutaneous and 15 metastatic) as possible evidence of vasculogenic mimicry. In addition we investigated the relationship between CD31 and CD34 expression and three pathological markers such as Clark's level, and skin ulceration, predictive of melanoma's aggressive behaviour, and mitotic index.
No cases of common melanocytic nevi immunoreacted with CD31 or CD34. Random CD31 immunoreactivity was present in 6% of Clark's level I/II, 50% of Clark's level III and 80% Clark's level IV/V. CD34 was negative in Clark's level I/II but randomly stained the 20% and 55% of level III and IV/V respectively. 66% (10/15) of metastatic melanomas were CD31 positive showing a canalicular immunostaining pattern, conversely CD34 expression was never found. 7/8 cutaneous ulcerated melanomas immunostained for CD31 and 4/8 for CD34. CD31 immunostained 88% high/intermediate MI, and 53% of low MI melanomas. CD34 decorated the 29% of high/intermediate and 38% of low MI melanomas.
CD31 and CD34 immunoreactivity closely parallel both the different morphologic steps of melanocytic tumor progression and the presence of histological parameters related to the aggressive behaviour. Their expression could be related to endothelial transdifferentiation of melanoma cells although a consequent functional role has not been demonstrated yet.
血管生成拟态,如先前在侵袭性黑色素瘤中所描述的,其特征是肿瘤内新生成有图案的血管通道,由无内皮细胞的PAS阳性基底膜组成,提供额外的微循环,以支持经典的肿瘤血管生成。
我们研究了两种内皮标志物CD31和CD34在60例黑色素瘤(45例原发性皮肤黑色素瘤和15例转移性黑色素瘤)肿瘤细胞中的免疫组化表达,作为血管生成拟态的可能证据。此外,我们还研究了CD31和CD34表达与三种病理标志物之间的关系,这三种病理标志物分别是Clark分级、皮肤溃疡,它们可预测黑色素瘤的侵袭行为,以及有丝分裂指数。
没有普通黑素细胞痣病例对CD31或CD34产生免疫反应。随机的CD31免疫反应性在Clark I/II级中占6%,在Clark III级中占50%,在Clark IV/V级中占80%。CD34在Clark I/II级中呈阴性,但分别在III级和IV/V级中随机染色20%和55%。66%(10/15)的转移性黑色素瘤CD31呈阳性,显示出小管状免疫染色模式,相反,从未发现CD34表达。7/8例皮肤溃疡黑色素瘤对CD31进行免疫染色,4/8例对CD34进行免疫染色。CD31对88%的高/中分裂指数黑色素瘤和53%的低分裂指数黑色素瘤进行免疫染色。CD34标记了29%的高/中分裂指数黑色素瘤和38%的低分裂指数黑色素瘤。
CD31和CD34免疫反应性与黑素细胞肿瘤进展的不同形态学阶段以及与侵袭行为相关的组织学参数密切平行。它们的表达可能与黑色素瘤细胞的内皮转分化有关,尽管尚未证明其相应的功能作用。